Evidence map›Paper›PMID 41063013›Full record

ArticleBMC public health2025

Optimizing surveillance post-pandemic: an evaluation of COVID-19 and other respiratory virus surveillance systems in the Philippines, April 2023.

Hannah Lofgren, Morgane Donadel, Romel S Lacson, Devon Ray Pacial, Alethea R de Guzman, Olivia Almendares, Philippines COVID-19 Surveillance System Evaluation Team

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hannah LofgrenCoronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. LSO8@cdc.gov.
Morgane DonadelDivision of Healthcare Quality and Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Romel S LacsonDivision of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Manila, Philippines.
Devon Ray PacialEpidemiology Bureau, Department of Health, Manila, Philippines.
Alethea R de GuzmanEpidemiology Bureau, Department of Health, Manila, Philippines.
Olivia AlmendaresCoronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Philippines COVID-19 Surveillance System Evaluation Team

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOn May 5, 2023, the World Health Organization removed the public health emergency of international concern (PHEIC) designation for the COVID-19 pandemic, noting reduced global risk of severe COVID-19 due to widespread infection and vaccine-induced immunity. Several months prior, the Philippine Department of Health (DOH) requested technical assistance from the U.S. Centers for Disease Control and Prevention (CDC) to evaluate its COVID-19 surveillance ecosystem and inform decision-making for sustainable respiratory virus monitoring. This manuscript describes the evaluation methodology, findings, and recommendations to inform these surveillance transitions.

methodsIn April 2023, an evaluation team from DOH, CDC, and Task Force for Global Health conducted a cross-sectional evaluation of six surveillance systems (COVID-19 case-based, traveler screening, and genomic surveillance; influenza-like illness surveillance, severe acute respiratory infection surveillance, and the Respiratory Syncytial Virus surveillance pilot) at 26 sites across three Philippine regions. Using tailored data collection tools, we analyzed systems’ structure, processes, attributes, and key performance indicators. Findings were categorized into three areas: surveillance system scope and design, system performance, and laboratory capacity.

resultsAlthough the DOH expanded and upgraded systems for COVID-19 surveillance, including universal case surveillance, contact tracing, and molecular testing and genomic sequencing, rapid development of multiple, isolated systems during the pandemic created inefficiencies and data discrepancies. Prioritizing COVID-19 surveillance strained staff capacity, impacting other surveillance efforts. Key findings included variable reporting completeness and timeliness and underutilization of sentinel sites. Challenges included fragmented data systems, heavy workloads, and resource limitations. Staff adaptability and dedication demonstrated their commitment to surveillance compliance. Progress in molecular testing and genomic sequencing was notable.

conclusionsPandemic-era surveillance of respiratory viruses requires adaptation to the interpandemic period. Recommendations focus on right-sizing COVID-19 surveillance while strengthening other surveillance systems, integrating respiratory virus surveillance systems, enhancing staff capacity, and improving stakeholder coordination. These findings offer valuable insights for transitioning to sustainable respiratory virus surveillance post-pandemic.

Indexed as

COVID-19Population SurveillanceRespiratory Tract InfectionsCross-Sectional StudiesHumansPandemicsPhilippinesSARS-CoV-2United StatesCOVID-19Cross-Sectional studiesGlobal healthSurveillance

Identifiers

PMID41063013
PMCPMC12506167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.